Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the autologous cell therapy market size evolved in recent years?

The market size for autologous cell therapy has expanded swiftly in the recent past. The industry, which is projected to increase from $10.28 billion in 2024 to $12.19 billion in 2025, will have a compound annual growth rate (CAGR) of 18.6%. The historic growth in the market can be credited to improvements in regenerative medicines, a rise in chronic diseases, a better grasp of cellular biology, patient inclination towards personalized treatments, as well as clinical success and favourable results.

What are the predictions for the autologous cell therapy market size in the coming years?

Anticipated to experience accelerated expansion in the upcoming years, the autologous cell therapy market is forecasted to enlarge up to “$23.33 billion by 2029 with a compound annual growth rate (CAGR) of 17.6%. The anticipated growth within this forecast period can be ascribed to the ongoing evolution in regenerative medicine, its increasing applications in various medical fields, progressive developments in cell culture methodologies, augmented investment and research efforts, regulatory backing, and standardization. Looking forward into the forecast period, we expect to see an emergence of trends such as the advent of automated manufacturing technologies, inclusion of biomarkers in treatment plans, the rise of point-of-care cell processing, extension beyond hematopoietic stem cells, and an increase in collaboration and partnerships within the industry.

Get your autologous cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

What key factors are fueling the growth of the autologous cell therapy market?

The high occurrence of chronic ailments, which are health conditions that last over a year and require long-term medical care, is likely to spur the expansion of autologous cell therapy. This is a promising treatment approach that involves the use of a person’s own cells that are grown and multiplied outside the body before being reinserted into the donor. For example, the US National Library of Medicine projected in January 2023 that by 2050, the number of US residents aged 50 and above with a minimum of 1 chronic disease would raise to 142.66 million. As such, the widespread prevalence of chronic diseases is propelling the autologous cell therapy market’s development.

How is the global autologous cell therapy market divided into key segments?

The autologous cell therapy market covered in this report is segmented –

1) By Therapy: Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies

2) By Source: Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources

3) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications

4) By End User: Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users

Subsegments:

1) By Autologous Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Adipose-Derived Stem Cell Therapy

2) By Autologous Cellular Immunotherapies: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Tumor-Infiltrating Lymphocyte (TIL) Therapy, Dendritic Cell Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10771&type=smp

Who are the key firms paving the way for growth in the autologous cell therapy market?

Major companies operating in the autologous cell therapy market include Bristol-Myers Squibb Company, Novartis AG, Vericel Corporation, Holostem Terapie Avanzate S.r.l., Pharmicell Co. Ltd., Opexa Therapeutics Inc., Tego Science AB, Brainstorm Cell Therapeutics Inc., Caladrius Biosciences Inc., Lineage Cell Therapeutics Inc., Castle Creek Biosciences Inc., Gilead Sciences Inc., Johnson & Johnson, CORESTEM Inc., Dendreon Pharmaceuticals LLC, Medipost Co. Ltd., PharmaJet Inc., Bioject Medical Technologies Inc., Medical International Technology Inc., INJEX Pharma AG, Lonza Group Ltd., Corning Incorporated, Takeda Pharmaceutical Company Limited, CSL Limited, AstraZeneca plc, Moderna Inc., Sinovac Biotech Ltd., Valneva SE, Bavarian Nordic A/S, Dynavax Technologies Corporation

Which trends are expected to transform the autologous cell therapy market?

The surge of technological advancements is an influential trend escalating in the autologous cell therapy market. To improve efficiency and maintain their operations, key players in the industry are resorting to automation of the autologous cell therapy process. For instance, in April 2022, Lonza, a company based in Switzerland that manufactures for the pharmaceutical, biotechnology, and nutrition industries, introduced the Cocoon platform. This state-of-the-art technology is constructed for manufacturing personalized cell and gene therapies. The Cocoon platform employs an automated closed system to significantly reduce contamination risks and ensure a sterile manufacturing procedure. Consequently, this enhances the quality, diminishes labor and material expenses, and facilitates effective scaling-up of autologous T-cell products.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10771

What regions are contributing significantly to the growth of the autologous cell therapy market?

North America was the largest region in the autologous cell therapy market in 2024.Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cellulose Esters and Ethers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulose-esters-and-ethers-global-market-report

Single-cell Analysis Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-global-market-report

Stem Cell Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: